Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2.

Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2. Ann Intern Med. 1993 Apr 15; 118(8):617-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.